BAFNAPH Share Price Target 2050

CAGR-based price projection for Bafna Pharmaceuticals Limited (BAFNAPH) targeting 2050, derived from official NSE exchange closing prices.

Bear Case (9.6% CAGR)
Rs 1,561
2050 Target
Base Case (23.9% CAGR)
Rs 29,872
2050 Target
Bull Case (69.5% CAGR)
Rs 55,597,585
2050 Target

Current Market Snapshot

CMP: Rs 174.58
52W High: Rs 193.97
52W Low: Rs 129.90
1Y CAGR: 53.5%
3Y CAGR: 23.9%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 191 Rs 216 Rs 296
2028 Rs 210 Rs 268 Rs 502
2029 Rs 230 Rs 332 Rs 851
2030 Rs 252 Rs 411 Rs 1,443
2031 Rs 276 Rs 510 Rs 2,446
2032 Rs 302 Rs 631 Rs 4,147
2033 Rs 331 Rs 782 Rs 7,032
2034 Rs 362 Rs 969 Rs 11,922
2035 Rs 397 Rs 1,201 Rs 20,214
2036 Rs 435 Rs 1,488 Rs 34,272
2037 Rs 477 Rs 1,843 Rs 58,107
2038 Rs 522 Rs 2,284 Rs 98,520
2039 Rs 572 Rs 2,829 Rs 167,040
2040 Rs 627 Rs 3,505 Rs 283,213
2041 Rs 687 Rs 4,343 Rs 480,184
2042 Rs 752 Rs 5,381 Rs 814,146
2043 Rs 824 Rs 6,666 Rs 1,380,373
2044 Rs 903 Rs 8,259 Rs 2,340,403
2045 Rs 989 Rs 10,233 Rs 3,968,120
2046 Rs 1,084 Rs 12,678 Rs 6,727,892
2047 Rs 1,187 Rs 15,707 Rs 11,407,047
2048 Rs 1,301 Rs 19,460 Rs 19,340,490
2049 Rs 1,425 Rs 24,110 Rs 32,791,531
2050 Rs 1,561 Rs 29,872 Rs 55,597,585

Other BAFNAPH Price Targets

2025 2026 2027 2028 2030 2035 2040

Frequently Asked Questions

What is the BAFNAPH share price target for 2050?

Based on historical growth analysis, the BAFNAPH share price target for 2050 ranges from Rs 1,561 (conservative) to Rs 29,872 (base case) to Rs 55,597,585 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of BAFNAPH?

The current market price of BAFNAPH (Bafna Pharmaceuticals Limited) is Rs 174.58. The 52-week high is Rs 193.97 and 52-week low is Rs 129.90.

Is BAFNAPH a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for BAFNAPH price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 9.6% CAGR), Base (23.9% CAGR), and Bull (optimistic at 69.5% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.